Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma | Synapse
January 1, 2021
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
For patients with intermediate-stage HCC, LEN-TACE sequential therapy may provide a deep response and favorable prognosis.